Europe — EMA
Orlistat Aurovitas
Orlistat, the active ingredient in Orlistat Aurovitas, is a lipase inhibitor presented as a oral tablet for gastrointestinal use. It reduces dietary fat absorption and is used in the management of obesity in adults.
Request sourcing
What is Orlistat?
Orlistat, the active ingredient in Orlistat Aurovitas, is a lipase inhibitor presented as a oral tablet for gastrointestinal use. It reduces dietary fat absorption and is used in the management of obesity in adults. GNH USA supplies Orlistat Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Orlistat Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Orlistat used for?
Orlistat is a weight‑management medication that acts on the gastrointestinal tract to limit fat absorption.
- Obesity: Helps reduce body weight when combined with a reduced‑calorie, low‑fat diet. - Overweight adults with additional risk factors: Assists in weight loss to improve metabolic parameters. - Post‑bariatric surgery maintenance: Supports maintenance of weight loss after surgical interventions. - Adjunct to lifestyle therapy: Enhances the effectiveness of diet and exercise programs. - Weight‑related comorbidities: Contributes to improvements in blood pressure and cholesterol levels when weight loss occurs.
What are the side effects of Orlistat?
Orlistat may cause a range of gastrointestinal and systemic reactions.
Common Side Effects: - Oily spotting: Occurs ... - Fatty/o ... ... - Gastrointestinal discomfort ... - Fecal urgency. - Increased ... - ...
Serious or Rare Side Effects: - Severe liver ... . - Acute ... . - Pancre . - .
What precautions apply to Orlistat?
It
- .
- … .... ... … "
